Items where Author is "Seifert, K. "

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Year | Item Type | Full Text
Jump to: 2017 | 2015 | 2014 | 2013 | 2011 | 2010 | 2009 | 2007 | 2006 | 2003 | 2002 | 2001
Number of items: 27.

2017

Meredith, EL; Kumar, A; Konno, A; Szular, J; Alsford, S; Seifert, K; Horn, D; Wilkinson, SR; (2017) Distinct activation mechanisms trigger the trypanocidal activity of DNA damaging prodrugs. Molecular microbiology. ISSN 0950-382X DOI: 10.1111/mmi.13767 Full text not available from this repository.

2015

Riede, O; Seifert, K; Oswald, D; Endmann, A; Hock, C; Winkler, A; Salguero, FJ; Schroff, M; Croft, SL; Juhls, C; (2015) Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine. Gene therapy, 22 (8). pp. 628-35. ISSN 0969-7128 DOI: 10.1038/gt.2015.35
[img]

2014

Das, S; Freier, A; Boussoffara, T; Das, S; Oswald, D; Losch, FO; Selka, M; Sacerdoti-Sierra, N; Schönian, G; Wiesmüller, KH; +10 more... (2014) Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasis. Science translational medicine, 6 (234). 234ra56. ISSN 1946-6234 DOI: 10.1126/scitranslmed.3008222 Full text not available from this repository.

Lamour, SD; Veselkov, KA; Posma, JM; Giraud, E; Rogers, ME; Croft, S; Marchesi, JR; Holmes, E; Seifert, K; Saric, J; (2014) Metabolic, Immune, and Gut Microbial Signals Mount a Systems Response to Leishmania major Infection. Journal of proteome research, 14 (1). pp. 318-329. ISSN 1535-3893 DOI: 10.1021/pr5008202 Full text not available from this repository.

Voak, AA; Seifert, K; Helsby, NA; Wilkinson, SR; (2014) Evaluating aziridinyl nitrobenzamide compounds as leishmanicidal prodrugs. Antimicrobial agents and chemotherapy, 58 (1). pp. 370-7. ISSN 0066-4804 DOI: 10.1128/AAC.01459-13 Full text not available from this repository.

2013

Mohamed-Ahmed, AHA; Les, KA; Seifert, K; Croft, SL; Brocchini, S; (2013) Noncovalent Connplexation of Amphotericin-B with Poly(alpha-glutamic acid). Molecular pharmaceutics, 10 (3). pp. 940-950. ISSN 1543-8384 DOI: 10.1021/mp300339p Full text not available from this repository.

Voak, AA; Gobalakrishnapillai, V; Seifert, K; Balczo, E; Hu, L; Hall, BS; Wilkinson, SR; (2013) An essential type I nitroreductase from Leishmania major can be used to activate leishmanicidal prodrugs. The Journal of biological chemistry, 288 (40). pp. 28466-76. ISSN 0021-9258 DOI: 10.1074/jbc.M113.494781 Full text not available from this repository.

2011

2010

Croft, SL; Seifert, K; (2010) Antiprotozoal agents. In: Finch, RogerG; Greenwood, David; Whitley, RichardJ; Norrby, SRagnar, (eds.) Antibiotic and Chemotherapy: Expert Consult (9th Edition). Saunders. ISBN 0702040649 Full text not available from this repository.

2009

2007

Seifert, K; Perez-Victoria, FJ; Stettler, M; Sánchez-Cañete, MP; Castanys, S; Gamarro, F; Croft, SL; (2007) Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo. International journal of antimicrobial agents, 30 (3). pp. 229-35. ISSN 0924-8579 DOI: 10.1016/j.ijantimicag.2007.05.007 Full text not available from this repository.

2006

Croft, SL; Seifert, K; Yardley, V; (2006) Current scenario of drug development for leishmaniasis. The Indian journal of medical research, 123 (3). pp. 399-410. ISSN 0971-5916 Full text not available from this repository.

Perez-Victoria, FJ; Sanchez-Canete, MP; Seifert, K; Croft, SL; Sundar, S; Castanys, S; Gamarro, F; (2006) Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use. Drug resistance updates , 9 (1-2). pp. 26-39. ISSN 1368-7646 DOI: 10.1016/j.drup.2006.04.001 Full text not available from this repository.

2003

Croft, SL; Seifert, K; Duchene, M; (2003) Antiprotozoal activities of phospholipid analogues. Molecular and biochemical parasitology, 126 (2). pp. 165-72. ISSN 0166-6851 DOI: 10.1016/S0166-6851(02)00283-9 Full text not available from this repository.

Seifert, K; Matu, S; Javier Perez-Victoria, F; Castanys, S; Gamarro, F; Croft, SL; (2003) Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). International journal of antimicrobial agents, 22 (4). pp. 380-387. ISSN 0924-8579 DOI: 10.1016/s0924-8579(03)00125-0 Full text not available from this repository.

2002

Walochnik, J; Duchêne, M; Seifert, K; Obwaller, A; Hottkowitz, T; Wiedermann, G; Eibl, H; Aspöck, H; (2002) Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp. Antimicrobial agents and chemotherapy, 46 (3). pp. 695-701. ISSN 0066-4804 DOI: 10.1128/AAC.46.3.695-701.2002 Full text not available from this repository.

2001

Seifert, K; Duchêne, M; Wernsdorfer, WH; Kollaritsch, H; Scheiner, O; Wiedermann, G; Hottkowitz, T; Eibl, H; (2001) Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolytica. Antimicrobial agents and chemotherapy, 45 (5). pp. 1505-10. ISSN 0066-4804 DOI: 10.1128/AAC.45.5.1505-1510.2001 Full text not available from this repository.

This list was generated on Sat Oct 21 09:55:56 2017 BST.